These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26404264)

  • 21. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
    Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated measures of placental growth factor, placental protein 13, and a disintegrin and metalloprotease 12 at first and second trimesters for preeclampsia screening.
    Boucoiran I; Suarthana E; Rey E; Delvin E; Fraser WB; Audibert F
    Am J Perinatol; 2013 Sep; 30(8):681-8. PubMed ID: 23386402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
    Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies.
    Boucoiran I; Thissier-Levy S; Wu Y; Wei SQ; Luo ZC; Delvin E; Fraser WD; Audibert F;
    Am J Perinatol; 2013 Aug; 30(7):607-12. PubMed ID: 23208763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
    Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
    Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
    Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review.
    Kuc S; Wortelboer EJ; van Rijn BB; Franx A; Visser GH; Schielen PC
    Obstet Gynecol Surv; 2011 Apr; 66(4):225-39. PubMed ID: 21756405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies.
    Maymon R; Trahtenherts A; Svirsky R; Melcer Y; Madar-Shapiro L; Klog E; Meiri H; Cuckle H
    Hypertens Pregnancy; 2017 Feb; 36(1):108-115. PubMed ID: 27835040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor.
    Rohra DK; Zeb A; Qureishi RN; Azam SI; Khan NB; Zuberi HS; Sikandar R
    Natl Med J India; 2012; 25(2):68-73. PubMed ID: 22686711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
    Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
    Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.
    Agarwal R; Chaudhary S; Kar R; Radhakrishnan G; Tandon A
    J Obstet Gynaecol; 2017 Oct; 37(7):877-882. PubMed ID: 28569565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential markers of preeclampsia--a review.
    Grill S; Rusterholz C; Zanetti-Dällenbach R; Tercanli S; Holzgreve W; Hahn S; Lapaire O
    Reprod Biol Endocrinol; 2009 Jul; 7():70. PubMed ID: 19602262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of screening for hypertensive disorders of pregnancy at 11-13 weeks in a Scandinavian population.
    Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
    Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1238-47. PubMed ID: 25146367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies.
    Liu Y; Zhao Y; Yu A; Zhao B; Gao Y; Niu H
    Arch Gynecol Obstet; 2015 Sep; 292(3):507-18. PubMed ID: 25716670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy.
    Parra-Cordero M; Rodrigo R; Barja P; Bosco C; Rencoret G; Sepúlveda-Martinez A; Quezada S
    Ultrasound Obstet Gynecol; 2013 May; 41(5):538-44. PubMed ID: 22807133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.